
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
Xiang Zhang, Shangyou Zheng, Chonghui Hu, et al.
Oncogene (2022) Vol. 41, Iss. 16, pp. 2372-2389
Open Access | Times Cited: 46
Xiang Zhang, Shangyou Zheng, Chonghui Hu, et al.
Oncogene (2022) Vol. 41, Iss. 16, pp. 2372-2389
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Cancer-associated fibroblasts: from basic science to anticancer therapy
Dakai Yang, Jing Liu, Hui Qian, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1322-1332
Open Access | Times Cited: 195
Dakai Yang, Jing Liu, Hui Qian, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1322-1332
Open Access | Times Cited: 195
Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation
Kangchun Wang, Xin Wang, Qi Pan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Kangchun Wang, Xin Wang, Qi Pan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
Qin Qin, Rong Yu, John Eriksson, et al.
Cancer Letters (2024) Vol. 591, pp. 216859-216859
Open Access | Times Cited: 22
Qin Qin, Rong Yu, John Eriksson, et al.
Cancer Letters (2024) Vol. 591, pp. 216859-216859
Open Access | Times Cited: 22
Extracellular vesicle–packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models
Shangyou Zheng, Chengyuan Hu, Qing Lin, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 756
Closed Access | Times Cited: 17
Shangyou Zheng, Chengyuan Hu, Qing Lin, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 756
Closed Access | Times Cited: 17
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Zhipeng Cao, Sadia Quazi, Sakshi Arora, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 5
Zhipeng Cao, Sadia Quazi, Sakshi Arora, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 5
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
FGF19‐Induced Inflammatory CAF Promoted Neutrophil Extracellular Trap Formation in the Liver Metastasis of Colorectal Cancer
Chen Li, Tianli Chen, Jialiang Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 24
Open Access | Times Cited: 35
Chen Li, Tianli Chen, Jialiang Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 24
Open Access | Times Cited: 35
Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating lncRNA DLEU1
Jie Zhao, Shaobo Yang, Caihong Lv, et al.
AJP Cell Physiology (2023) Vol. 324, Iss. 5, pp. C1039-C1052
Closed Access | Times Cited: 21
Jie Zhao, Shaobo Yang, Caihong Lv, et al.
AJP Cell Physiology (2023) Vol. 324, Iss. 5, pp. C1039-C1052
Closed Access | Times Cited: 21
Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer
Shangyou Zheng, Qing Tian, Yuan Yuan, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 18
Shangyou Zheng, Qing Tian, Yuan Yuan, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 18
New insights into the interaction between m6A modification and lncRNA in cancer drug resistance
Yizhou Jin, Zhipeng Fan
Cell Proliferation (2023) Vol. 57, Iss. 4
Open Access | Times Cited: 17
Yizhou Jin, Zhipeng Fan
Cell Proliferation (2023) Vol. 57, Iss. 4
Open Access | Times Cited: 17
The role of transcription factors in the crosstalk between cancer-associated fibroblasts and tumor cells
Xiaoyan Zhang, Meng Zhang, Hui Sun, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 7
Xiaoyan Zhang, Meng Zhang, Hui Sun, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 7
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6
m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma
Lin Zhu, Zhenkun Huang, Jiliang Qiu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Lin Zhu, Zhenkun Huang, Jiliang Qiu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27
Reversal of chemotherapy resistance in gastric cancer with traditional Chinese medicine as sensitizer: potential mechanism of action
Chencong Zhou, Kaihan Wu, M. Gu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Chencong Zhou, Kaihan Wu, M. Gu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation
Rihua He, Chonghui Hu, Yuan Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Rihua He, Chonghui Hu, Yuan Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Role of noncoding RNA and protein interaction in pancreatic cancer
Zhang Li, Tingting Zhang, Yang Xiao-juan, et al.
Chinese Medical Journal (2025)
Open Access
Zhang Li, Tingting Zhang, Yang Xiao-juan, et al.
Chinese Medical Journal (2025)
Open Access
Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance
Jiajia Li, Sicong Hou, Ziping Ye, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2115-2115
Open Access | Times Cited: 20
Jiajia Li, Sicong Hou, Ziping Ye, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2115-2115
Open Access | Times Cited: 20
LncRNAs in Immune and Stromal Cells Remodel Phenotype of Cancer Cell and Tumor Microenvironment
Wenbin Li, Haohan Zhang, You Zuo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3173-3185
Open Access | Times Cited: 4
Wenbin Li, Haohan Zhang, You Zuo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3173-3185
Open Access | Times Cited: 4
NF-κB signaling pathway in tumor microenvironment
Yaning Cao, Yongqing Yi, Chongxu Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Yaning Cao, Yongqing Yi, Chongxu Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1
Renpeng Xia, Chonghui Hu, Yuancheng Ye, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 4
Open Access | Times Cited: 10
Renpeng Xia, Chonghui Hu, Yuancheng Ye, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 4
Open Access | Times Cited: 10
Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges
Zhichen Jiang, Xiaohao Zheng, Min Li, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1135-1169
Closed Access | Times Cited: 10
Zhichen Jiang, Xiaohao Zheng, Min Li, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1135-1169
Closed Access | Times Cited: 10
Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer
Jiaqiang Ren, Shuai Wu, Tong Su, et al.
Cancer Medicine (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 3
Jiaqiang Ren, Shuai Wu, Tong Su, et al.
Cancer Medicine (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 3
Gastric Cancer Actively Remodels Mechanical Microenvironment to Promote Chemotherapy Resistance via MSCs‐Mediated Mitochondrial Transfer
Xin He, Li Zhong, Nan Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 47
Open Access | Times Cited: 3
Xin He, Li Zhong, Nan Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 47
Open Access | Times Cited: 3
Modulating multidrug resistance to drug-based antitumor therapies through NF-κB signaling pathway: mechanisms and perspectives
Dapeng Wu, Sai Tian, Wenjing Zhu
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 503-515
Closed Access | Times Cited: 7
Dapeng Wu, Sai Tian, Wenjing Zhu
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 503-515
Closed Access | Times Cited: 7